BioMarin Pharmaceutical Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
Asset Breakdown FY2025
Total Assets: $7.59B
Liabilities Breakdown FY2025
Total Liabilities: $1.51B
Asset Breakdown
Total Assets: $7.59B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $1.31B | 17.3% |
| Accounts Receivable | $908.2M | 12.0% |
| Inventory | $1.30B | 17.1% |
| Property, Plant & Equipment | $952.5M | 12.5% |
| Goodwill | $196.2M | 2.6% |
| Intangible Assets | $213.8M | 2.8% |
| Other Assets | $2.71B | 35.7% |
Liabilities Breakdown
Total Liabilities: $1.51B
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $0 | 0.0% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $1.51B | 100.0% |